Therapeutic Asset Ratings

204 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
FLORTAUCIPIR Alzheimer Disease	Eli Radiopharma	P4	BBB (73)
Florbetaben Alzheimer Disease	National Institute of Mental Health (NIMH)	P4	BBB (72)
Donanemab Alzheimer Disease	Michael Rafii, MD, PhD	P4	BB (70)
Memantine Hydrochloride Alzheimer Disease	Bigespas LTD	P4	BB (67)
Semaglutide Alzheimer Disease	The Methodist Hospital Research Institute	P3	BB (66)
PITTSBURGH COMPOUND B UNLABELLED Alzheimer Disease	Yale University	P4	BB (65)
IZAFLORTAUCIPIR Alzheimer Disease	Lantheus Biosciences Ltd.	P3	BB (65)
mk-6240 Alzheimer Disease	Universitaire Ziekenhuizen KU Leuven	P3	BB (65)
ct1812 Alzheimer Disease	Cognition Therapeutics	P2	BB (65)
Remternetug Alzheimer Disease	Washington University School of Medicine	P3	B (63)
Sra-333 Alzheimer Disease	Wyeth is now a wholly owned subsidiary of Pfizer	P1	B (62)
Emestedastat Alzheimer Disease	Actinogen Medical	P2/3	B (61)
Daridorexant Alzheimer Disease	Douglas Mental Health University Institute	P4	B (60)
gv-971 Alzheimer Disease	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	P4	B (60)
Tricaprilin Alzheimer Disease	Cerecin	P3	B (60)
Humulin R Alzheimer Disease	Pennington Biomedical Research Center	P2/3	B (60)
Bezisterim Alzheimer Disease	Neurological Associates of West Los Angeles	P3	B (59)
Nabilone Alzheimer Disease	Sunnybrook Health Sciences Centre	P3	B (59)
Spironolactone Alzheimer Disease	Emory University	P4	B (58)
MELATONIN Alzheimer Disease	Saint Vincent's Hospital, Korea	P3	B (58)
Suvorexant Alzheimer Disease	Washington University School of Medicine	P3	B (58)
VITAMIN D Alzheimer Disease	Rune Skovgaard Rasmussen	P3	B (58)
Immunoglobulin G4-kappa, anti-[Homo sapiens LGALS3 (galectin 3)], humanized monoclonal antibody (gamma4 heavy chain humanized (1-442) [VH (Homo sapiens IGHV1-301 (88.7%) -(IGHD) -IGHJ601 (93.3%), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116)-Homo sapiens IGHG401, nG4m(a) CH2 L92, G4v5 h P10 (CH1 (117-214), hinge 1-12 S10>P (224)(215-226), CH2 L92 (305) (227-336), CH3 (337-441), CHS K2>del (442)) (117-442)], (130-219')-disulfide with kappa light chain humanized (1'-219') [V-KAPPA(Homo sapiens IGKV2D-2902 (89.0%) -IGKJ201(100%), CDR-IMGT [11.3.9] (27-37.55-57.94-102)) (1'-112') -Homo sapiens IGKC01 (100%), Km3 A45.1(158), V101 (196) (113'-219')]; dimer (222-222'':225-225'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa) Alzheimer Disease	TrueBinding, Inc.	P2	B (58)
Simufilam Alzheimer Disease	Cassava Sciences, Inc.	P3	B (57)
Phenserine Alzheimer Disease	Helse Stavanger HF	P2/3	B (57)

Showing 1 to 25 of 204 assets

PreviousPage 1 of 9Next